Penumbra Inc (PEN) Projected Price to Earnings

Diversification into neurovascular and peripheral surgery reduces Penumbra, Inc. (PEN) dependence on local insurance systems. The company's consensus P/E forecast visualizes the objectivity of market valuations, where the 53.50 level indicates the status of the parameter. High FDA barriers and unique patents create a technological moat, while demand for Lightning Flash systems drives expansion into global markets.

PEN - penumbrainc.com Market Cap to Projected Earnings over the range 07/04/2022 - 11/15/2026

Financial and market metric breakdowns for penumbrainc.com (PEN)

- current price and projected stock value:

Stock Quotes Penumbra Inc|PEN - Analyst Consensus Forecast

- market capitalization details:

Market Valuation Penumbra Inc|PEN - Aggregate Business Value

- issuer book value statistics:

Book Value per Share Penumbra|PEN - Book Valuation of Business|Market Capitalization to Book Value Ratio penumbrainc.com|PEN - Cumulative Company Assets

- debt and solvency information:

- earnings and market ratios statistics:

PEN - Net Financial Result|Projected Future Earnings Penumbra, Inc.|PEN - Price to Earnings Ratio|Forward P/E Multiple Penumbra Medical|PEN - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Penumbra Medical|PEN - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Penumbra|PEN - Earnings per share for the trailing year|Quarterly EPS earnings growth penumbrainc.com|PEN - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Penumbra, Inc.

- revenue and sales proceeds data:

PEN - Company Total Sales Volume|Company Future Sales Volume Penumbra Inc|PEN - P/S Multiple|Forward P/S Multiple Penumbra, Inc.|PEN - Annual Revenue Growth (Last Twelve Months)

Fundamental company analysis:penumbrainc.com

The analyst is evaluating the issuer's credit quality through the lens of expected returns. Innovations in neurovascular surgery and demand for thrombectomy aspiration systems ensure the stability of Penumbra, Inc. (PEN). The company's forward P/E ratio compares current market capitalization with projected earnings, filtering out market noise. The dynamics of this metric reveal asset overvaluation or hidden liquidity risks. It is critical for the investor to determine whether the multiple is justified by the pace of international expansion.

Competitors of Penumbra, Inc. (PEN)